| Application no. and date | 13773767.2 (espacenet) (Federated) (European Patent Register), 20131008 | | Patent/reg. no. and date | DK/EP 2906595, 20170816 | | Publication date | 20150819 | | Priority no. and date | EP 12306232, 20121009, EP 13305222, 20130227 | | EP pub. no. and date |
EP 2906595 20150819 | | Effective date | | | Applicant/owner | SANOFI, 54 rue La Boétie
75008 Paris, FR | | Applicant ref. no. | SAN 56665PEP-WO/WWmsc[DE2012-151EPEPT]13773767.2[F | | Inventor | Wagner, Michael, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
BOSSART, Martin, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
STENGELIN, Siegfried, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
EVERS, Andreas, c/o Sanofi-Aventis Deutschland Gmbh
65926 Frankfurt am Main, DE,
HAACK, Torsten, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE,
HENKEL, Bernd, c/o Sanofi-Aventis Deutschland GmbH
65926 Frankfurt am Main, DE | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | A61K 38/00 (2006.01) , A61K 38/22 (2006.01) , A61K 38/26 (2006.01) , A61K 38/28 (2006.01) , A61K 45/06 (2006.01) , C07K 14/605 (2006.01) | | Title | EXENDIN-4-DERIVATER SOM GLP1/GLUCAGON-DOBBELTAGONISTER | | Int. application no. | EP2013070882 | | Int. publication no. | WO2014056872 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
